New first-line treatment option for metastatic kidney cancer
The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment option for patients with metastatic […]
» Read moreHome »
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help […] Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor […]
Adding targeted therapy to treatment extends lives of those with metastatic breast cancer
HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer
